Lovitz, J&J poke fun at psoriasis

Share this article:
Lovitz, J&J poke fun at psoriasis
Lovitz, J&J poke fun at psoriasis
Johnson & Johnson's Centocor Ortho Biotech is launching a psoriasis awareness campaign featuring sufferer Jon Lovitz.

The funnyman has shot a series of comical videos that will air nationally and be housed on the campaign website, SeriousAboutPsoriasis.com. The campaign got its start when Lovitz left a voicemail for Craig Stoltz, director for product communications on immunology brands at Centocor Ortho Biotech.

“It was a voice that I instantly recognized,” Stoltz blogged on JNJBTW.com. “It belonged to renowned Saturday Night Live actor and comedian, Jon Lovitz, who was calling with a proposition: help him raise awareness for a disease that he'd suffered with for nearly a decade.” Lovitz only recently got his psoriasis under control with the help of a dermatologist.

Video PSAs, directed by Airplane and Naked Gun director Jerry Zucker, include Lovitz singing a psoriasis-themed parody of the Maroon 5 song “This Love” and a beachside vignette in which Lovitz scares off a half-man, half-crab creature by flashing it.

The campaign also includes radio PSAs.

Psoriasis affects about 7.5 million Americans, making it the most prevalent autoimmune disease in the US, according to the National Psoriasis Foundation, which is collaborating with Centocor Ortho Biotech on the campaign. The company compensated Lovitz for his participation in the effort.

J&J said it would donate one dollar to the National Psoriasis Foundation for each of the first 10,000 people who share the video of the song parody.

Share this article:
You must be a registered member of MMM to post a comment.


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...